ACAD

Acadia Pharmaceuticals Inc

May 20 • 04:00PM ET

20.95

+0.47 2.29 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: ALKS AXSM NBIX SUPN PRTA

| Held by: IJR VTI XBI VB IWM VBK VXF IBB SPSM IJT

Scroll to Statements

Index	RUT	P/E	9.54	EPS (ttm)	2.20	Insider Own	1.49%	Shs Outstand	171.09M	Perf Week	-5.55%
Market Cap	3.59B	Forward P/E	27.26	EPS next Y	0.77	Insider Trans	-1.69%	Shs Float	168.68M	Perf Month	-3.90%
Enterprise Value	2.79B	PEG	-	EPS next Q	0.06	Inst Own	96.64%	Short Float	6.61%	Perf Quarter	-13.89%
Income	375.65M	P/S	3.28	EPS this Y	-83.06%	Inst Trans	-1.21%	Short Ratio	5.83	Perf Half Y	-12.74%
Sales	1.10B	P/B	2.87	EPS next Y	97.30%	ROA	27.44%	Short Interest	11.16M	Perf YTD	-21.56%
Book/sh	7.29	P/C	4.21	EPS next 5Y	-14.49%	ROE	37.32%	52W High	28.35 -26.10%	Perf Year	-3.41%
Cash/sh	4.97	P/FCF	31.58	EPS past 3/5Y	- -	ROIC	29.19%	52W Low	19.69 6.40%	Perf 3Y	-13.82%
Dividend Est.	-	EV/EBITDA	30.06	Sales past 3/5Y	27.48% 19.39%	Gross Margin	91.47%	Volatility	3.18% 3.36%	Perf 5Y	-2.92%
Dividend TTM	-	EV/Sales	2.54	EPS Y/Y TTM	61.40%	Oper. Margin	7.39%	ATR (14)	0.75	Perf 10Y	-38.45%
Dividend Ex-Date	-	Quick Ratio	3.48	Sales Y/Y TTM	9.93%	Profit Margin	34.30%	RSI (14)	42.51	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	3.59	EPS Q/Q	-81.36%	SMA20	-4.32%	Beta	0.85	Target Price	31.65
Payout	0.00%	Debt/Eq	0.04	Sales Q/Q	9.72%	SMA50	-3.54%	Rel Volume	0.88	Prev Close	20.48
Employees	798	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-11.47%	Avg Volume	1.91M	Price	20.95
IPO	May 27, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-60.40% -4.34%	Trades		Volume	1,704,695	Change	2.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)